Abstract Details

Title Interferon Beta-1a (Avonex[reg]) Delays the Onset of Clinically Definite MS over 5 Years of Treatment: Results from CHAMPIONS Study

Topic

Presentation(s)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Valentyna Honchar, MD (Capital Neurology)	No disclosure on file
Michael Dobbs, MD (University of Texas Rio Grande Valley of Medicine)	Dr. Dobbs has received publishing royalties from a publication relating to health care.
Edison Campos, MD (University of Kentucky)	No disclosure on file
Fernando Alarcon, MD (Hospital Eugenio Espejo)	No disclosure on file
	No disclosure on file

��ɫ��